Company intelligence / Profile preview

Raysight

Ownership: Private
Development stage: Other

Overview

Raysight, also known as Ruixin Intelligent Medical, develops artificial intelligence-powered equipment for the detection and real-time monitoring of cardiovascular diseases. The company focuses on integrating advanced AI algorithms with medical hardware to provide accurate and timely diagnostic information. Details on clinical validation or regulatory approvals are not specified in available sources[3].

Therapeutic areas: Cardiovascular
Modalities: DeviceArtificial intelligence-based diagnostic toolReal-time monitoring equipment (hardware/software)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Raysight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raysight.

Explore the full profile